Abstract
Mast cells are immune inflammatory cells residing in peripheral tissues and acting as sentinels. They are involved in diverse physiological processes such as tissue repair or wound healing (reviewed in Artuc et al. 1999), and they participate in defence against parasitic infection and other aspects of innate and acquired immunity (reviewed in Mekori and Metcalfe 2000; Wedemeyer and Galli 2000). In susceptible allergic individuals, this protection system is unbalanced and mast cells play a deleterious role in the pathophysiology of allergic disorders (reviewed in Holgate 2000; Bingham and Austen 2000; Hart 2001). An increase in the number of infiltrated mast cells, often in an activated state, is indeed observed at sites of allergic inflammation such as in the bronchus of asthmatic patients (Laitinen et al. 1993; Pesci et al. 1993; Bradding et al. 1994; Kassel et al. 2001a). Mast cells express high affinity IgE receptors (FcεRI) on their surface, which when aggregated by an antigen (allergen) recognized by specific receptor-bound IgE, initiate biochemical events leading to the release of inflammatory mediators (Metzger 1992).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agis H, Willheim M, Sper WR, Wilfing A, Krömer E, Kabrna E, Spanblöchl E, Strobl H, Geissler K, Spittler A, Boltz-Nitulescu G, Madjic O, Lechner K, Valent P (1993) Monocytes do not make mast cells when cultured in the presence of SCF. Characterization of the circulating mast cell progenitor as a c-kit+, CD34+, Ly, CD14-, CD17, colony forming cell. J Immunol 151: 4221–4227
Alessi DR, Smythe C Keyse SM (1993) The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene 8: 2015–2020
Artuc M, Hermes B, Steckelings UM, Grutzkau A, Henz BM (1999) Mast cells and their mediators in cutaneous wound healing–active participants or innocent bystanders? Exp Dermatol 8: 1–16
Austen KF, Boyce JA (2001) Mast cell lineage development and phenotypic regulation. Leuk Res 25: 511–518
Barnes, PJ (1998) Antiinflammatory action of glucocorticoids: molecular mechanisms. Clin Sci 94: 557–572
Barnes PJ, Pedersen S, Busse WW (1998) Efficacy and safety of inhaled corti- costeroids. New developments. Am J Respir Crit Care Med 157: S1 - S53
Barnes NC, Burke CM, Poulter LW, Schleimer RP (2000) The anti-inflammatory profile of inhaled corticosteroids: biopsy studies in asthmatic patients. Respir Med 94: 516 - S21
Beato M, Herrlich P, Schutz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83: 851–857
Beaven MA, Baumgartner, RA (1996) Downstream signals initiated in mast cells by Fc epsilon RI and other receptors. Curr Opin Immunol 8: 766–772
Benhamou M, Ninio E, Salem P, Hieblot C, Bessou G, Pitton C, Liu FT, Mencia-Huerta JM (1986) Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of PAF-acether formation and of beta-hexosaminidase release by dexamethasone. J Immunol 136: 1385–1392
Bingham CO 3rd, Austen KF (2000) Mast-cell responses in the development of asthma. J Allergy Clin Immunol 105: S527 - S534
Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST (1994) Interleukin-4, interleukin-5, and interleukin-6 and tumor necrosis factor-alpha in normal and asthmatic airways–evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 10: 471–480
Bradding P Feather IH, Wilson S, Holgate ST, Howarth PH (1995) Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med 151: 1900–1906
Caelles C, Gonzalez-Sancho JM, Munoz A (1997) Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev 11: 3351–3364
Cato AC, Wade E (1996) Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 18: 371–378
Cissel DS, Beaven, MA (2000) Disruption of Raf-1/Heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. J Biol Chem, 275: 7066–7070
Collado-Escobar D, Cunha-Melo JR, Beaven MA (1990) Treatment with dexamethasone down-regulates IgE-receptor-mediated signals and up-regulates adenosine-receptor-mediated signals in a rat mast cell (RBL-2H3) line. J Immunol 144: 244–250
Croxtall JD, Choudhury Q, Flower RJ (2000) Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism. Br J Pharmacol 130: 289–298
Daeron M, Sterk AR, Hirata F, Ishizaka T (1982) Biochemical analysis of glucocorticoid-induced inhibition of IgE-mediated histamine release from mouse mast cells. J Immunol 129: 1212–1218
Dorfman,K, Carrasco D, Gruda M, Ryan C, Lira S A, Bravo, R (1996) Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene 13: 925–931
Eklund KK, Humphries DE, Xia Z, Ghildyal N, Friend DS, Gross V, Stevens RL (1997) Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE-receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases. J Immunol 158: 4373–4380
Fernandes D, Guida E, Koutsoubos V, Harris T, Vadiveloo P, Wilson JW, Stewart AG (1999) Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracel-lular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol 21: 77–88
Finotto S, Mekori YA, Metcalfe DD (1997) Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells — in vitro and in vivo evidence in murine systems. J Clin Invest 99: 1721–1728
Garrington TP, Ishizaka T, Papst PJ, Chayama K, Webb S, Yujiri T, Sun W, Sather S, Russell DM, Gibson SB, Keller G, Gelfand EW, Johnson GL (2000) MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells. EMBO J 19: 5387–5395
Gewert K, Hiller G, Sundler R (2000) Effects of dexamethasone on mitogenactivated protein kinases in mouse macrophages: implications for the regulation of 85 kDa cytosolic phospholipase A(2). Biochem Pharmacol 60: 545–551
Gonzalez MV, Gonzalez-Sancho JM, Caelles C, Munoz A, Jimenez B (1999) Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells. FEBS Lett 459: 272–276
Gonzalez MV, Jimenez B, Berciano MT, Gonzalez-Sancho JM, Caelles C, Lafarga M, Munoz A (2000) Glucocorticoids antagonize AP-1 by inhibiting the activation/phosphorylation of JNK without affecting its subcellular distribution. J Cell Biol 150: 1199–1208
Groom LA, Sneddon AA, Alessi DR, Dowd S, Keyse SM (1996) Differential regulation of the MAP, SAP and RK/p38 kinases by Pystl, a novel cytosolic dual-specificity phosphatase. EMBO J 15: 3621–3632
Hart PH (2001) Regulation of the inflammatory response in asthma by mast cell products. Immunol Cell Biol 79: 149–153
Hata D, Kitaura J, Hartman SE, Kawakami Y, Yokota T, Kawakami T (1998) Bruton’s tyrosine kinase-mediated interleukin-2 gene activation in mast cells dependence on the c-Jun N-terminal kinase activation pathway. J Biol Chem 273: 10979–10987
Hayashi C, Sonoda T, Nakano T, Nakayama H, kitamura Y (1985) Mast-cell precursors in the skin of mouse embryos and their deficiency in embryos of Sl/Sld genotype. Dev Biol 109: 234–241
Heiman AS, Crews FT (1984) Inhibition of immunoglobulin, but not polypeptide base-stimulated release of histamine and arachidonic acid by anti-inflammatory steroids. J Pharmacol Exp Ther 230: 175–182
Her E, Reiss N, Braquet P, Zor U (1991) Characterization of glucocorticoid inhibition of antigen-induced inositolphosphate formation by rat basophilic leukemia cells: possible involvement of phosphatases. Biochim Biophys Acta 1133: 63–72
Herrlich P (2001) Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20: 2465–2475
Hirasawa N, Scharenberg A, Yamamura H, Beaven MA, Kinet JP (1995a) A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by Fc epsilon Rl is not shared by a G protein-coupled receptor. J Biol Chem 270: 10960–10967
Hirasawa N, Santini F, Beaven M A (1995b) Activation of the mitogen-activated protein kinase/cytosolic phospholipase A2 pathway in a rat mast cell line. J Immunol 154: 5391–5402
Hirasawa N, Sato Y, Fujita Y, Mue S, Ohuchi K (1998) Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells. J Immunol 161: 4939–4943
Hirasawa N, Murakami A, Ohuchi K (2001) Expression of a 74-kDa histidine decarboxylase protein in a macrophage-like cell line RAW 2647 and inhibition by dexamethasone. Eur J Pharmacol 418: 23–28
Holgate ST (2000) The role of mast cells and basophils in inflammation. Clin Exp Allergy 30: S28 - S32
Hulley PA, Gordon F, Hough FS (1998) Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 154) by dexamethasone: role of protein phosphatases. Endocrinology 139: 2423–2431
Irani AA, Nilsson G, Ashman LK, Schwartz LB (1995) Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant stem cell factor. Immunology 84: 72–78
Kassel O, Schmidlin F, Duvernelle C, de Blay F, Frossard N (1998) Up-and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture. Mol Pharmacol 54: 1073–1079
Kassel O, de Blay F, Duvernelle C, Olgart C, Israel-Biet D, Krieger P, Moreau L, Muller C, Pauli G, Frossard N (2001a) Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy 31: 1432–1440
Kassel O, Sancono A, Krätzschmar J, Kreft B, Stassen M, Cato AC (2001b) Glucocorticoids inhibit MAP-kinase via increased expression and decreased degradation of MKP-1. EMBO J 20: 7108–7116
Kim Y-K, Nakagawa N, Nakano K, Sulakvelidze I, Dolovich J, Denburg J (1997) Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids. J Allergy Clin Immunol 100: 389–399
Kimata M, Inagaki N, Kato T, Miura T, Serizawa I, Nagai H (2000) Roles of mitogen-activated protein kinase pathways for mediator release from human cultured mast cells. Biochem Pharmacol 60: 589–594
Kimata M, Abe T, Yamaguchi I, Mito K, Tsunematsu M, Inagaki N, Nagai H (2001) Prednisolone inhibits an IgE-mediated late-phase allergic cutaneous reaction by interfering with the activation of mast cells in mice. Pharmacology 62: 17–22
Kobayashi H, Ishizuka T, Okayama Y (2000) Human mast cells and basophils as sources of cytokines. Clin Exp Allergy 30: 1205–1212
König H, Ponta H, Rahmsdorf HJ, Herrlich P (1992) Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupancy in vivo. EMBO J 11: 2241–2246
Laitinen LA, Laitinen A, Haahtela T (1993) Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 147: 697–704
Mekori YA, Metcalfe DD (2000) Mast cells in innate immunity. Immunol Rev 173: 131–140
Metzger H (1992) The receptor with high affinity for IgE. Immunol Rev 125: 37–48
Nechushtan H, Razin E (1998) Deciphering the early-response transcription factor network in mast cells. Trends Immunol 19: 441–444
Nissen RM, Yamamoto KR (2000) The glucocorticoid receptor inhibits NFKB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes and Dev 14: 2314–2329
Novotny V, Prieschl EE, Csonga R, Fabjani G, Baumruker T (1998) Nrfl in a complex with fosB, c-jun, junD and ATF2 forms the APl component at the TNF alpha promoter in stimulated mast cells. Nucleic Acids Res 26: 5480–5485
Olgart C, Frossard N (2001) Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids. Eur Respir J 18: 115–121
Offermanns S, Jones SV, Bombien E, Schultz G (1994) Stimulation of mitogen-activated protein kinase activity by different secretory stimuli in rat basophilic leukemia cells. J Immunol 152: 250–261
Pelletier C, Varin-Blank N, Rivera J, Iannascoli B, Marchand F, David B, Weyer A, Blank U (1998) FceRI-mediated induction of TNF-a gene expression in the RBL-2H3 mast cell line: regulation by a novel NF-KB-like nuclear binding complex. J Immunol 161: 4768–4776
Pesci A, Foresi A, Bertorelli G, Chetta A, Oliven D (1993) Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects. Am Rev Respir Dis 147: 684–689
Pettiford SM, Herbst R (2000) The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP. Oncogene 19: 858–869
Pons F, Freund V, Kuissu H, Mathieu E, Olgart C, Frossad N (2001) Nerve growth factor secretion by human lung epithelial A549 cells in pro-and anti-inflammatory conditions. Eur J Pharmacol 428: 365–369
Rider L G, Hirasawa N, Santini F, Beaven MA (1996) Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J Immunol 157: 2374–2380
Rottem M, Okada T, Goff JP, Metcalfe DD (1994) Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+ Fc(epsilon)RI(—) cell population. Blood 84: 2489–2496
Schmidt-Choudhury A, Furuta GT, Lavigne JA, Galli SJ, Wershil BK (1996) The regulation of tumor necrosis factor-a production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-a by distinct mechanisms. Cell Immunol 171: 140–146
Song JS, Haleem-Smith H, Arudchandran R, Gomez J, Scott PM, Mill JF, Tan TH, Rivera J (1999) Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway. J Immunol 163: 802–810
Sousa AR, Lane SJ, Soh C, Lee TH (1999) In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation. J Allergy Clin Immunol 104: 565–574
Sun H, Charles CH, Lau LF, Tonks NK (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487–493
Swantek JL, Cobb MH, Geppert TD (1997) Jun-N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor a (TNF-a) translation: glucocorticoids inhibit TNF-a translation by blocking JNK/SAPK. Mol Cell Biol 17: 6274–6282
Tchekneva E, Serafin WE (1994) Kirsten sarcoma virus-immortalized mast cell lines Reversible inhibition of growth by dexamethasone and evidence for the presence of an autocrine growth factor. J Immunol 152: 5912–5921
Turner H, Kinet J-P (1999) Signalling through the high-affinity IgE receptor FccRI. Nature 402: B24 — B30
Ventura JJ, Roncero C, Fabregat I, Benito M (1999) Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor alpha in fetal rat hepatocyte primary cultures. Hepatology 29: 849–857
Virchow JC, Julius P, Lommatzsch M, Luttmann W, Renz H, Braun A (1998) Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med 158: 2002–2005
Wedemeyer J, Galli SJ (2000) Mast cells and basophils in acquired immunity. Br Med Bull 56: 936–955
Wershil BK, Furuta GT, Lavigne JA, Choudhury AR, Wang ZS, Galli SJ (1995) Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J Immunol 154: 1391–1398
Widén C, Zilliacus J, Gustafsson JA, Wikstrom AC (2000) Glucocorticoid receptor interaction with 14–3–3 and Raf–1, a proposed mechanism for crosstalk of two signal transduction pathways. J Biol Chem 275: 39296 – 39301
Yamaguchi M, Hirai K, Komiya A, Miyamasu M, Furomoto Y, Teshima R, Ohta K, Morita Y, Galli SJ, Ra C, Yamamoto K (2001) Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone. Int Immunol 13: 843–851
Yee NS, Paek I, Besmer P (1994) Role of kit-ligand in proliferation and suppression of apoptosis in mast cells: basis for radiosensitivity of White spotting and Steel mutant mice. J Exp Med 179: 1777–1787
Zhang C, Baumgartner RA, Yamada K, Beaven MA (1997) Mitogen-activated protein ( MAP) kinase regulates production of tumor necrosis factor-alpha and release of arachidonic acid in mast cells. J Biol Chem 272: 13397–13402
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kassel, O., Cato, A.C.B. (2002). Mast Cells as Targets for Glucocorticoids in the Treatment of Allergic Disorders. In: Cato, A.C.B., Schäcke, H., Asadullah, K. (eds) Recent Advances in Glucocorticoid Receptor Action. Ernst Schering Research Foundation Workshop, vol 40. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04660-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-04660-9_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-04662-3
Online ISBN: 978-3-662-04660-9
eBook Packages: Springer Book Archive